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First Polish implantations of the smallest  
minimally invasive implantable loop recorder
Pierwsze w Polsce implantacje najmniejszych, małoinwazyjnych rejestratorów zdarzeń
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According to the current guidelines in patients with infrequent, but recurrent, and undiagnosed syncope, an implantable 
loop recorder (ILR) might be a very useful diagnostic tool to establish the cause. At present, the Medtronic Reveal LINQ™ 
Insertable Cardiac Monitoring System is the smallest ILR available on the market. Its innovative features include: simple 
and minimally invasive delivery system, up to three years longevity, magnetic resonance imaging compatibility, wireless 
communication, and remote monitoring with internet access. On 29 September 2014, concurrently in two Polish referral 
cardiology centres, implantation of a Reveal LINQ™ was performed. Patient 1 was a 39-year-old man in whom for the 
past four years syncope and episodes of unconsciousness and injuries occurred. Despite numerous studies, including 
electrocardiogram (ECG) Holter monitoring, echocardiography, tilt test, and electrophysiological study (EPS) with ajmaline 
challenge, the reason for these symptoms was not revealed. Patient 2 was a 63-year-old man with a history of periodic 
fainting and complete loss of consciousness. Basic diagnostics of syncope, including repeated Holter ECG monitoring, 
echocardiography, coronary angiography, and neurological examination, did not revealed significant abnormalities. How-
ever, due to his high body weight, tilt was not performed and the patient did not agree to EPS. Images from the procedure 
are presented in Figure 1. A film of the procedure is available at: https://www.youtube.com/watch?v=6B7Zz0NDygI. Due 
to low ventricular sensed amplitude in Patient 2 there 
was a need for device displacement with two skin inci-
sions. After 62 days of follow-up Patient 2 developed 
full syncope. When he regained consciousness he 
recorded transmission with a rhythm in the normal 
range; however, in the memory there was stored an 
episode of significant pause (Fig. 2A). The patient was 
given a permanent pacemaker. Patient 1, 84 days 
after implantation, is still asymptomatic, and the only 
recorded findings have been numerous (42) episodes 
of sinus tachycardia (Fig. 2B).
Figure 2. A. Record during the complete loss of consciousness in Patient 2. The episode of pause that was automatically re-
corded during a syncopal event (meeting the criteria programmed into the device). The device keeps an episode stored in its 
memory of the first 30 s of the episode and up to 27 s of intracardiac electrogram before the end of the episode; B. Sample 
episode of a sinus tachycardia with heart rate histogram recorded in Patient 1
Figure 1. Implanting set of Reveal LINQ™ and postprocedural 
effect in Patient 2
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